As both Grm1 and BMP signaling processes are reduced in AD, this may be a mechanism by which changes in glutamatergic signaling coordinate with other cell populations to trigger wider modifications in signaling between cell types. The gene discussed is GRM1; the disease is Alzheimer disease.